Stock Price

CELLECTAR BIOSCIENCES INC

Why Cellectar Biosciences’ Stock Plunged 44% and How Investors Can Respond

Why Cellectar Biosciences’ Stock Plunged 44% and How Investors Can Respond

Sharp 44% fall: Why Cellectar Biosciences’ biotech stock plunged below its 200‑day average and what investors should watch for next.

23/10/2026, 22:57

3 minutes to read

CLRB Stock Gains 4.07% on Oct 22: Cellectar’s Upturn Amid Biotech Volatility

CLRB Stock Gains 4.07% on Oct 22: Cellectar’s Upturn Amid Biotech Volatility

Explore Cellectar Biosciences’ 4% price rebound and why its oncology pipeline may fuel future gains.

22/10/2026, 19:43

2 minutes to read

CLRB Stock Surge: Cellectar Biosciences Climbs 9.82% as Market Outlook Shifts

CLRB Stock Surge: Cellectar Biosciences Climbs 9.82% as Market Outlook Shifts

Explore Cellectar Biosciences’ latest market data: 9.82% rise, 52‑week high $4.70, and key insights on related biotech stocks.

21/10/2026, 17:41

2 minutes to read